deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02361099

SENTINEL : Impact of the Use of a Web-application for the Detection of Lung Cancer Relapse (SENTINEL)

Phase 3 Multicentric Randomized Study Assessing Self-reported Symptoms Transmitted Via an Internet Web-application Sentinel Versus Conventional Follow-up in Patients With High Risk Lung Cancer (SENTINEL)

Sponsor: Sivan Innovation Ltd.

Conditions Lung Cancer
Interventions Monitoring by SENTINEL application
Updated 9 times since 2017 Last updated: Jun 25, 2020 Started: Jun 3, 2014 Primary completion: Dec 31, 2017 Completion: Mar 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Lung Cancer and is currently completed. Sivan Innovation Ltd. leads this study, which shows 9 recorded versions since 2014 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotTerminated~Aug 2018 – ~Jul 2020 · 23 months · monthly snapshotCompleted~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotCompleted~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Feb 2025 — Sep 2025 [monthly]

    Completed PHASE3

  3. Sep 2024 — Feb 2025 [monthly]

    Completed PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  5. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

▶ Show 4 earlier versions

  1. Jul 2020 — Jan 2021 [monthly]

    Completed PHASE3

  2. Aug 2018 — Jul 2020 [monthly]

    Completed PHASE3

    Status: Terminated → Completed

  3. Jun 2018 — Aug 2018 [monthly]

    Terminated PHASE3

  4. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sivan Innovation Ltd.
  • Weprom
Data source: Weprom

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations